VAERS Explorer
Back to explore

Report #2872367

Received Nov 12, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
Oct 29, 2025
Onset
Oct 30, 2025
Days to onset
1
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (3)

ErythemaPainPruritus

Symptom narrative

Red pain itchy; Red; Pain; This non-serious case was reported by a consumer and described the occurrence of pruritus in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 29-OCT-2025, the patient received Shingrix. On 30-OCT-2025, 1 days after receiving Shingrix, the patient experienced pruritus (Verbatim: Red pain itchy), erythema (Verbatim: Red) and pain (Verbatim: Pain). The outcome of the pruritus, erythema and pain were not resolved. It was unknown if the reporter considered the pruritus, erythema and pain to be related to Shingrix. It was unknown if the company considered the pruritus, erythema and pain to be related to Shingrix. Additional Information: GSK Receipt Date: 02-NOV-2025 The symptoms were not treated. Event outcome date was reported as 02-NOV-2025. The batch number was not provided and a request for this information has been made.